Chang-Dong Yeo, Ph.D.

Affiliations: 
2008 University of Illinois, Urbana-Champaign, Urbana-Champaign, IL 
Area:
Mechanical Engineering
Google:
"Chang-Dong Yeo"

Parents

Sign in to add mentor
Andreas A. Polycarpou grad student 2008 UIUC
 (Rough surface interactions of micro/nano-scale contact systems.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Paik SH, Yeo CD, Jeong JE, et al. (2019) Prevalence and analysis of tobacco use disorder in patients diagnosed with lung cancer. Plos One. 14: e0220127
Lim JU, Yeo CD, Rhee CK, et al. (2019) Comparison of clinical characteristics and overall survival between spirometrically diagnosed chronic obstructive pulmonary disease (COPD) and non-COPD never-smoking stage I-IV non-small cell lung cancer patients. International Journal of Chronic Obstructive Pulmonary Disease. 14: 929-938
Choi SY, Kim HW, Jeon SH, et al. (2019) Comparison of PANAMutyper and PNAClamp for Detecting KRAS Mutations from Patients With Malignant Pleural Effusion. In Vivo (Athens, Greece). 33: 945-954
Lim JU, Yeo CD, Kang HS, et al. (2019) Elevated pretreatment platelet-to-lymphocyte ratio is associated with poor survival in stage IV non-small cell lung cancer with malignant pleural effusion. Scientific Reports. 9: 4721
Jeon SH, Kim HW, Kim BN, et al. (2019) Comparison of PNA Clamping-assisted Fluorescence Melting Curve Analysis and PNA Clamping in Detecting Mutations in Matched Tumor Tissue, Cell Block, Pleural Effusion and Blood of Lung Cancer Patients With Malignant Pleural Effusion. In Vivo (Athens, Greece). 33: 595-603
Kang N, Choi SY, Kim BN, et al. (2019) Hypoxia-induced cancer stemness acquisition is associated with CXCR4 activation by its aberrant promoter demethylation. Bmc Cancer. 19: 148
Lim JU, Yeo CD, Rhee CK, et al. (2018) Overall survival of driver mutation-negative non-small cell lung cancer patients with COPD under chemotherapy compared to non-COPD non-small cell lung cancer patients. International Journal of Chronic Obstructive Pulmonary Disease. 13: 2139-2146
Lim JU, Yeo CD, Kang HS, et al. (2018) Prognostic value of platelet count and lymphocyte to monocyte ratio combination in stage IV non-small cell lung cancer with malignant pleural effusion. Plos One. 13: e0200341
Kang HS, Shin AY, Yeo CD, et al. (2018) A lower level of forced expiratory volume in one second predicts the poor prognosis of small cell lung cancer. Journal of Thoracic Disease. 10: 2179-2185
Yeo CD, Lee MK, Lee SH, et al. (2018) Indicators and Qualitative Assessment of Lung Cancer Management by Health Insurance Review and Assessment Service (HIRA) of Korea in 2015. Tuberculosis and Respiratory Diseases. 81: 19-28
See more...